Mizuho healthcare sector expert Jared Holz explained: "Now without a GLP in its (near-term) pipeline, it is now feasible that PFE could look to bring in an asset (external business development) should it choose to stay in the weight-loss game to some extent." Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics
10.1196/annals.1317.005 114
Your provider may recommend: Reviewing nutrition basics (protein, fiber, hydration) Adjusting habits and activity goals Updating dosage or timing when appropriate Checking sleep and stress factors The goal is sustainable progress, not extreme restriction
If youre ready to get started
This triple-action approach creates a more comprehensive effect on metabolism compared to single or dual-receptor medications
Lixisenatide (Adlyxin)